© Foto: picture alliance / Global Travel Images
© Foto: picture alliance / Global Travel Images
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | Galderma: Zulassungsanträge für Nemolizumab in vier Ländern angenommen | ||
Di | Galderma SA: Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries |
Galderma has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic dermatitis in Australia... ► Artikel lesen | |
30.04. | Galderma Reports Strong First-Quarter Growth, Shares Climb on Positive Outlook | ||
24.04. | Switzerland's Galderma posts 12.4% jump in first-quarter sales | ||
24.04. | Galderma Achieves 1.071 Billion USD in the First Quarter after Going Public, Up 12.4% YOY |
Unternehmen / Aktien | Kurs | % |
---|---|---|
GALDERMA GROUP AG | - | - |